Supplemental Table 1 was identified through a high-throughput screening campaign involving 290,000 compounds and determined to be a NOD1-selective scaffold. After confirmation of the initial results, the SAR analysis was undertaken by both analog-by-catalog approach and a medicinal chemistry effort creating additional analogs. Compounds CID1088438 and CID1088439 (entries 1 and 2) were purchased and re-synthesized. Analogs were either synthesized in-house (entries 3, 4, 6 and 7) or commercially available (entry 5). IC 50 values were obtained after primary screen (hit confirmation) and further compound selectivity panel analysis. Details on compound synthesis and purification will be published elsewhere and deposited into PubChem, as well as a more detailed SAR analysis wherein 78 compounds were synthesized. These studies indicate that the bioactivity of the 2-aminobenzimidale series of NOD1 inhibitory compounds is dependent on the nature of some substituents represented as Y and R 3 . The presence of sulfonyl group as a linker and "Y" as the amino group are crucial for high inhibitory activity and selectivity of these compounds. Electron donating substituents (R 3 ) on the phenyl also favor the high potency of these compounds. 
(active compound; Noditinib-1), in the presence (+) or absence (-) of 10 g/ml -tri-DAP for 19 hours, followed by standard RNA purification and first-strand cDNA synthesis.
RNA levels (y-axis) were normalized by beta-actin expression. Relative values (indicated above bars) were obtained after comparison to basal expression (mean value = 1). The values presented are averages of at least three replicates (+/-standard deviation). Fluorescence polarization was measured after 10 min. Values are expressed in milliPolars (mP), presented as averages of two replicates (+ SEM).
Supplemental

Supplemental Figure 9, related to Figures 2 and 3. Effects of compounds on NOD1
ubiquitination status. HEK 293T cells from 10-cm plates were co-transfected with 6.5 g of each plasmids encoding hemaglutinin (HA)-tagged ubiquitin, VSV-tagged RIP2 and 6xHis-FLAG-tagged NOD1 then further treated after 1 day with 5 M of CID-1088438 (active compound) or CID-44229067 (inactive analog). After 24h treatment, cells were lysed and equal amounts of protein were immunoprecipitated (I.P.) using anti-FLAG beads. Total protein lysates (≈50 g) and FLAG immunoprecipitates were analyzed by immunoblotting. Actin levels were assessed as loading control (left). FLAG immunoprecipitates were additionally analyzed by immunoblotting using K48-and K63-specific ubiquitin antibodies (right). NOD1 and RIP2 proteins are indicated (arrows). (control), and further treated with 5 M of prototypical NOD1 inhibitor (CID-1088438) or its inactive analog (CID-44229067). After 24h treatment, cells were lysed and equal amounts of protein were pulled-down using Ni/NTA agarose beads. Total protein lysates (≈60 g) and Ni/NTA-bound proteins were analyzed by immunoblotting. Actin levels were assessed as loading control. Note that active compound CID-1088438 causes more 6His-FLAG-NOD1 protein (but not NOD2) pull-down with Ni/NTA resin, possibly reflecting a conformational change. Interaction of over-expressed 6His-FLAG-NOD1
with Myc-NOD1, RIP2, and SGT-1 was not inhibited by active compound. Lentiviral production and purification. Human full-length cDNA sequences encoding NOD1 and NOD2 were modified by PCR (Advantage 2 kit, Clontech) to encode 6xHis-and flag-epitopes tags at their N-terminal, and respectively subcloned into XbaI and XhoI sites of a CMV-driven lentiviral construct pCSC-SP-PW. For functional assays, a thirdgeneration of lentiviral vector was also utilized to introduce a 5X κB-responsive firefly luciferase cassette (Tergaonkar et al., 2003) , allowing the expression of the reporter gene under the control of five tandem HIV NF-B response elements (gift from I. Verma, Salk Institute, CA, USA). Vesicular stomatitis virus G envelope protein-pseudotyped lentiviruses were prepared and purified as described (Naldini et al., 1996; Pfeifer et al., 2002; Pfeifer and Verma, 2001 ). Vector concentrations were estimated according to biological titer provided by GFP expressing lentiviruses (control). 
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Gene reporter assays. HEK293T or 697 cells containing integrated 5×
High throughput screening (HTS). HEK293T cells containing stably integrated NF-B-
luciferase (Luc) reporter were harvested as described, with the exception that after removing supernatant, cell pellets were washed once in Dulbecco's phosphate buffered saline and further re-suspended in assay medium supplemented with 0.62% DMSO to a density of 2x10 Plates were then incubated for 60 minutes at room temperature. Next, 2 µl of γ-tri-DAP at 1.874 µg/ml (Anaspec, Freemont, CA) in assay medium (for a final concentration of 0.75 µg/ml γ-tri-DAP) was added to columns 3-48 and 2 µl assay medium added to columns 1-2 using a Multidrop Combi. Final concentration of test compounds in assay was 4 µM. Final DMSO concentration was 1%. Plates were centrifuged for 30 seconds at 1000 rpm (200xG) on an Eppendorf 5810 centrifuge and incubated 16 hours at 37ºC in 5% CO 2 . After incubation, plates were removed from incubator and allowed to equilibrate to room temperature for 10-15 minutes. Three microliters of Steady-Glo® luciferase assay detection reagent (Promega) was added to entire plate using Multidrop Combi and immediately centrifuged for 30 seconds on a VSpin™ integrated microplate centrifuge at 1500 rpm (Velocity11/Agilent Technologies) and incubated for 20 minutes at room temperature. Luminescence was measured on a Viewlux microplate imager (PerkinElmer). For the purpose of a single concentration primary NOD2 counter-screen, a stable line based on the HEK293T-NF-B-Luc constitutively over-expressing NOD2 was developed as a surrogate. Experimental procedures were followed but in the absence of any inducer.
ELISA. For IL-8 ELISA, MCF-7 cells stably expressing His6-FLAG-tagged NOD1 or NOD2 were produced by lentivirus infection. Cells were cultured up to 90% confluency.
Assays were initiated using 50,000 MCF-7 cells per well (in 100 l volume) of a 96-well transparent culture plate. After cell attachment, the culture medium was replaced with Phenol Red-free medium containing 5 g/ml -tri-DAP, 5 g/ml MDP or 5 ng/ml TNF plus 1.5 g/ml cycloheximide and incubated for 16 to 24 hours at 37 were ressuspended with 1X sample buffer (50 mM Tris [pH 6.8], 2% SDS, 10% glycerol, 0.01% bromophenol blue, 5% 2-mercaptoethanol) and analyzed by SDS-PAGE. For subcellular fractionation, cytosolic fractions were obtained by extensive ressuspension of cell pellets into buffer A (10 mM Hepes 7.5, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT and protease inhibitors). Remaining pellet was extensively ressuspended into buffer C (20 mM Hepes 7.5, 25% glycerol, 450 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA and protease inhibitors) to isolate nuclear sub-fraction, followed by ressuspension of final pellet (cell membrane sub-fraction) into RIPA extraction buffer (Thermo Scientific).
Immunoblotting was performed using respective antibodies. Total lysates (50-60 g) and subcellular fractions (10 g) were also immunoblotted after protein quantification (BioRad Protein Assay).
Protein expression and purification. NOD1 protein was purified from 293 Freestyle were loaded on a column and a wash step of 500 x CV (column volume) was performed, followed by elution using 0.1 M glycine pH 3.5. Protein concentration was determined using BCA Protein Assay (Thermo Scientific).
Fluorescent polarization assay (FPA)
. FPAs were performed as described previously using various purified recombinant NOD1, NLRP1ΔLRR, or HSP70 ATP binding domain proteins and FITC-conjugated ATP (Fluorescein-12-ATP, PerkinElmer) (Zhai et al., 2006) . Briefly, recombinant proteins were incubated in 384-well black round-bottom plates with 10 nM of FITC-ATP in a total volume of 20 l in the dark. Fluorescence polarization was measured using a LJL Analyst HT plate reader (Molecular Devices) in PBS, 0.005% Tween-20. IC 50 determinations were performed using GraphPad Prism TM software.
NMR spectroscopy.
1 H-NMR experiments were performed at 25°C on a 500-MHz Bruker Avance spectrometer (Bruker, Madison, WI) equipped with a 5-mm TXI probe.
Compounds were dissolved in fully deuterated DMSO (d 6 -methylsulfoxide; SigmaAldrich) to a concentration of 10 mM. 1H NMR reference spectra were collected at a final concentration of 50 µM in 50 mM Tris-HCl, pH7.5, 150 mM NaCl buffer with or without 5 µM of 6xHis-Flag-NOD1, 6xHis-Bcl-X L , or 6xHis-Bid proteins. All 1H-NMR spectra were obtained with the carrier position set to the water peak signal using WATERGATE TM . NMR data were processed and analyzed with xwinplot.
RNA analysis. Total RNA was extracted using RNeasy 
